(Q41489053)

English

Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis

scientific article published on 3 February 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

multicenter clinical trial

0 references

follicular lymphoma

1 reference

based on heuristic

inferred from title

author name string

K Lerch

1

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

A H Meyer

2

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

A Stroux

3

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

C Hirt

4

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

U Keller

5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

A Viardot

6

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

R Marks

7

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

S Schreiber

8

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

A Pezzutto

9

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

C W Scholz

10

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

publication date

3 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

981-988

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Incidence, risk factors and outcome of histological transformation in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Review of survival analyses published in cancer journals

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Suboptimal dosing of rituximab in male and female patients with DLBCL.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2303-5

21 January 2018

Identifiers

10.1007/S00277-015-2303-5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41489053&oldid=1922268145"